The development of a multimodal prediction model based on CT and MRI for the prognosis of pancreatic cancer.

PURPOSE

To develop and validate a hybrid radiomics model to predict the overall survival in pancreatic cancer patients and identify risk factors that affect patient prognosis.

METHODS

We conducted a retrospective analysis of 272 pancreatic cancer patients diagnosed at the First Affiliated Hospital of Soochow University from January 2013 to December 2023, and divided them into a training set and a test set at a ratio of 7:3. Pre-treatment contrast-enhanced computed tomography (CT), magnetic resonance imaging (MRI) images, and clinical features were collected. Dimensionality reduction was performed on the radiomics features using principal component analysis (PCA), and important features with non-zero coefficients were selected using the least absolute shrinkage and selection operator (LASSO) with 10-fold cross-validation. In the training set, we built clinical prediction models using both random survival forests (RSF) and traditional Cox regression analysis. These models included a radiomics model based on contrast-enhanced CT, a radiomics model based on MRI, a clinical model, 3 bimodal models combining two types of features, and a multimodal model combining radiomics features with clinical features. Model performance evaluation in the test set was based on two dimensions: discrimination and calibration. In addition, risk stratification was performed in the test set based on predicted risk scores to evaluate the model's prognostic utility.

RESULTS

The RSF-based hybrid model performed best with a C-index of 0.807 and a Brier score of 0.101, outperforming the COX hybrid model (C-index of 0.726 and a Brier score of 0.145) and other unimodal and bimodal models. The SurvSHAP(t) plot highlighted CA125 as the most important variable. In the test set, patients were stratified into high- and low-risk groups based on the predicted risk scores, and Kaplan-Meier analysis demonstrated a significant survival difference between the two groups (p < 0.0001).

CONCLUSION

A multi-modal model using radiomics based on clinical tabular data and contrast-enhanced CT and MRI was developed by RSF, presenting strengths in predicting prognosis in pancreatic cancer patients.